The First 1,000 Days and the Dementia Question: What a 1953 Sugar Rationing Experiment Actually Reveals

Posted on August 3, 2026 by Maurice Preter MD

The First 1,000 Days and the Dementia Question: What a 1953 Sugar Rationing Experiment Actually Reveals On September 26, 1953, the British government lifted the last remaining food restrictions from the Second World War—sugar rationing. Overnight, the average UK citizen’s … Continue reading →

Posted in Aging, China, Clinical & Theoretical, Complementary - Alternative Medicine, dietary, epigenetics, Health, International And Concierge Medicine | Tagged , , , , , , , |

Muscle as Medicine: Skeletal Muscle Mass and 10-Year CVD Risk

Posted on December 12, 2025 by Maurice Preter MD

The ATTICA study shows that higher skeletal muscle mass predicts lower cardiovascular disease risk over 10 years. A neuropsychiatric analysis of muscle, heart, and brain health. Muscle as Medicine: Skeletal Muscle Mass and 10-Year Cardiovascular Risk — What the ATTICA … Continue reading →

Posted in Aging, Clinical & Theoretical, Complementary - Alternative Medicine, epigenetics, Events, Fifth Avenue Concierge Medicine, Health, Lifestyle Psychiatry, metabolic, Neuropsychiatry of Affluence, News, Psychiatry/Neurology, Psychological Resilience | Tagged , , , , , , , , , , , , , , |

Ultra-processed food exposure and adverse health outcomes

Posted on February 10, 2025 by Maurice Preter MD

Ultra-processed food exposure and adverse health outcomes Continue reading →

Posted in Affective Neuroscience, Aging, dietary, epigenetics | Tagged , , , |

Low-dose lithium

Posted on February 5, 2025 by Maurice Preter MD

Low-dose lithium

Low-dose lithium has emerged as a promising treatment option for various mental health and neurological conditions. This mineral, naturally occurring in food and water supplies, has shown potential benefits when used in doses much lower than those prescribed for bipolar disorder. Continue reading →

Posted in News, Aging, dietary, epigenetics, Fifth Avenue Concierge Medicine, Health, metabolic, new treatments, Psychiatry/Neurology | Tagged , , , , , , , |

Bryan Johnson, the 47-year-old tech entrepreneur known for his extreme anti-aging efforts, has recently discontinued his use of rapamycin, a drug he had been taking for nearly five years as part of his longevity regimen[2][8]. This decision has sparked renewed discussion about the potential risks and benefits of using drugs like rapamycin for anti-aging purposes.

Posted on January 16, 2025 by Maurice Preter MD

Bryan Johnson, the 47-year-old tech entrepreneur known for his extreme anti-aging efforts, has recently discontinued his use of rapamycin, a drug he had been taking for nearly five years as part of his longevity regimen. This decision has sparked renewed … Continue reading →

Posted in Aging, Fifth Avenue Concierge Medicine, Health, News, Psychiatry/Neurology | Tagged , , , , , |